Angion Biomedica's Unattributed - II Round

Angion Biomedica raised a round of funding on January 11, 2017.

Angion Biomedica is a clinical stage biopharmaceutical company. The company is focused on discovery and development of drugs that harness the body's reparative and regenerative systems to prevent or l…

Articles about Angion Biomedica's Unattributed - II Round: